Phase II Study of Docetaxel Alternating With Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Anti-Cancer Drugs - United States
doi 10.1097/00001813-200001000-00002
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2000
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)